(A diabeteszes ketoacidzis a cukorbetegsg egyik szvdmnye, amely olyankor alakul ki, amikor a szervezet nem kpes lebontatni a glkzt, mert nem ll rendelkezsre elegend inzulin)
In the US, individuals with overweight or obesity using GLP-1 RAs has increased from 21,000 in 2019 to 174,000 in 2023, which is a 700% increase in usage 11
Eating quickly can make the nausea worse and make you eat more food
Glucosedependent insulinotropic polypeptide is a growth factor for beta (INS1) cells by pleiotropic signaling
Weight loss patches are marketed as an easy, non-invasive way to support weight loss by delivering active ingredients through the skin
GLP-1 receptor agonists such as semaglutide (marketed under brand names Ozempic, Wegovy, and Rybelsus) and the dual GIP/GLP-1 agonist tirzepatide (marketed under brand names Mounjaro and Zepbound) are FDA-approved prescription medications for specific uses in type 2 diabetes management and, in some cases, chronic weight management